A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza
Clinical trial NCT05052697 · COMPLETED
Trial details
- NCT number
- NCT05052697
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-13
- Primary completion
- 2023-01-27
- Enrollment
- 1158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.